Research On the Identification of Novel Antigens and The Optimization of Therapeutic Strategies in Cancer Immunotherapy Through Single-Cell Sequencing

Peixuan Li

doi:10.54097/zbj7n333

Authors

Peixuan Li

DOI:

https://doi.org/10.54097/zbj7n333

Keywords:

Single-cell sequencing; Cancer immunotherapy; Tumor markers; Therapeutic strategy optimization; Cellular heterogeneity.

Abstract

With the advancement of single-cell sequencing, we are now capable of analyzing the heterogeneity within tumors with increased precision, revealing the complex interactions between the tumor microenvironment and immune cell subgroups. Studies mentioned in the articles demonstrate significant cell heterogeneity in various cancers at genomic, transcriptomic, and proteomic levels. In particular, single-cell technologies aid in identifying cell-type-specific genetic lineage effects, for example, in the context of influenza infection and T cell surveillance. Current study focuses on the application of single-cell sequencing in cancer immunotherapy and the exploration of novel antigen identification and optimization of therapeutic strategies. The introduction of new strategies, such as the refinement of electrochemical immuno-sensors, synthesis of novel small molecule drugs, and optimized detection of genetic mutations, contributes collectively to the accurate identification of tumor markers and innovative development of therapeutic methods. The integration of treatment schemes and patient survival analysis further guides the implementation of personalized medicine. In summary, the application of single-cell sequencing and its integration with the optimization of therapeutic strategies promises revolutionary advancements in the field of cancer immunotherapy.

Downloads

Download data is not yet available.

References

[1] Osipov A, Saung MT, Zheng L, Murphy AG. Small molecule immunomodulation: the tumor microenvironment and overcoming immune escape. J Immunother Cancer. 2019.

[2] Li YL, Chen CH, Chen JY. Single-cell analysis reveals immune modulation and metabolic switch in tumor-draining lymph nodes[J]. OncoImmunology, 2020.

[3] Tong S, Luo X, Xu B. Personalized mobile marketing strategies[J]. Journal of the Academy of Marketing Science, 2020.

[4] Lotfollahi M, Naghipourfar M, Luecken MD. Query to reference single-cell integration with transfer learning[J]. bioRxiv, 2020.

[5] Li C, Sun YD, Yu GY, Cui JR, Lou Z, Zhang H, Huang Y, Bai CG, Deng LL, Liu P, Zheng K, Wang YH, Wang QQ, Li QR, Wu QQ, Liu Q, Shyr Y, Li YX, Chen LN, Wu JR, Zhang W, Zeng R. Integrated Omics of Metastatic Colorectal Cancer. Cancer Cell. 2020 Nov 9;38(5):734-747.e9.

[6] Randolph HE, Mu Z, Fiege JK. Single-cell RNA-sequencing reveals pervasive but highly cell type-specific genetic ancestry effects on the response to viral infection[J]. bioRxiv, 2020.

[7] Carter KM, Matthew C. Novel Methods for Next-Generation Sequencing Data with Applications in Microbiome Studies[D]. The University of Arizona, 2020.

[8] Mannakee B. Statistical Methods for Improving Low Frequency Variant Calling in Cancer Genomics[D]. The University of Arizona, 2020.

[9] Govindarajan M, Wohlmuth C, Waas M. High-throughput approaches for precision medicine in high-grade serous ovarian cancer[J]. J Hematol Oncol, 2020.

[10] Saremi NF. A Genomic Approach to Studying the Evolutionary Consequences of Population Declines[D]. University of California, Santa Cruz, 2020.

[11] Tan JHJ, Kong SL, Tai JA. Experimental and bioinformatics considerations in cancer application of single cell genomics[J]. Comput Struct Biotechnol J, 2020.

[12] Schafflick D, Xu CA, Hartlehnert M, Cole M, Schulte-Mecklenbeck A, Lautwein T, Wolbert J, Heming M, Meuth SG, Kuhlmann T, Gross CC, Wiendl H, Yosef N, Meyer zu Horste G. Integrated single cell analysis of blood and cerebrospinal fluid leukocytes in multiple sclerosis. Nature Communications, 2020.

[13] Hong L, Aminu M, Li S, Lu X, Petranovic M, Saad MB, Chen P, Qin K, Varghese S, Rinsurongkawong W, Rinsurongkawong V, Spelman A, Elamin YY, Negrao MV, Skoulidis F, Gay CM, Cascone T, Gandhi SJ, Lin SH, Lee PP, Carter BW, Wu CC, Antonoff MB, Sepesi B, Lewis J, Gibbons DL, Vaporciyan AA, Le X, Lee JJ, Roy-Chowdhuri S, Routbort MJ, Gainor JF, Heymach JV, Lou Y, Wu J, Zhang J. Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer[J]. 2020.

[14] Kelly CM, Klemen ND, Bartlett EK. The emerging role of immunotherapy for the treatment of sarcoma[J]. Journal of Surgical Oncology, 2020.

[15] Martínez Rojas FJ. Desarrollo de un Inmunosensor Electroquímico para la Detección de Biomarcador Específico de Cáncer[D]. Pontificia Universidad Católica de Chile (Chile), 2020.

[16] Johnson AM. The Role of the Tumor Microenvironment on the Progression of Lung Cancer[D]. University of Colorado Denver, Anschutz Medical Campus, 2020.

[17] Guenther DC, Anderson GH, Karmakar S, Anderson BA, Didion BA, Guo W, Verstegen JP, Hrdlicka PJ. Invader probes: Harnessing the energy of intercalation to facilitate recognition of chromosomal DNA for diagnostic applications. Chemical Science, 2015.

[18] Altıntop MD, Zeytun E, Dilek EZ. Yeni Tiyazol Türevlerinin Sentezi ve Antikanser Etki Çalışmaları[D]. Anadolu University (Turkey), 2020.

[19] Zou W, Luo X, Gao M, et al. Optimization of Cancer Immunotherapy on the Basis of PD-L1 Distribution and Function[D]. British Journal of Pharmacology, 2023.